Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 08 Sep 2025

Deadlier Than HIV Or Malaria: TB Stays India's Top Infectious Killer, Says Study

NDTV Profit

In contrast to other illnesses such as cancer, and cardiovascular diseases which are more frequent in older populations, TB affects the young.

TB remains India's top infectious killer, deadlier than HIV or malaria

Business Standard | 08 Sep 2025

Pharmaceuticals & Biotech.

SECTOR | 06 Sep 2025

WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis, and cancer drugs

Business Line

The updated EML and EMLc (for children) also includes medicines for psoriasis, haemophilia and blood-related disorders

Pharmaceuticals & Biotech.

SECTOR | 05 Sep 2025

India gears up for GLP-1 generics as WHO lists diabetes drugs as essential

Business Standard

WHO adds GLP-1 drugs for type 2 diabetes to its Essential Medicines List, as Indian pharma firms prepare to launch generics amid surging demand and patent expirations

Pharmaceuticals & Biotech.

SECTOR | 04 Sep 2025

Congo Declares Ebola Virus Outbreak As 15 Deaths Reported

NDTV Profit

Samples tested on Wednesday in the capital, Kinshasa, confirmed the cause of the outbreak as Ebola Zaire, a strain of the Ebola virus.

Pharmaceuticals & Biotech.

SECTOR | 01 Sep 2025

The Wisdom of Plagues: Book traces lessons not learned from pandemics

Business Standard

Covid-19 was the saddest pandemic NYT reporter Donald G McNeil ever covered. Now he shows how outbreaks like AIDS and Ebola foreshadowed the next in patterns, responses, and impact

Pharmaceuticals & Biotech.

SECTOR | 31 Aug 2025

Repurposed drug statin found to slow cancer growth, boost treatment support

Business Standard

Statins, which help treat high cholesterol, have been found to slow down the growth of colorectal tumours, according to a new study, making researchers consider the possibility of repurposing the drug to support cancer treatment. However, more clinical trials are needed to provide scientific evidence before statins can become part of standard cancer treatment, they said. Drug repurposing, an alternative to the conventional way of developing medicines from scratch, accelerates the pace of discovery since existing medicines and compounds being used for it have already passed safety tests. Owing to a need to reduce the cost of developing drugs, the idea has gained traction in recent years with advances in computing power, artificial intelligence and bioinformatics helping in the identification of new uses for existing drugs more systematically and quickly. Cancer is among the multiple diseases, including rheumatoid arthritis and HIV/AIDS, for which drug repurposing is being...

Pharmaceuticals & Biotech.

SECTOR | 30 Aug 2025

Medical Devices Demand To Surge If GST Rate Slashed, Says Poly Medicure MD

NDTV Profit

Poly Medicure MD expects domestic product volumes to rise as the healthcare sector grows 1215% yearly.

Pharmaceuticals & Biotech.

SECTOR | 24 Aug 2025

US aid cuts leave South Africa's most vulnerable struggling for HIV drugs

Business Standard

On a warm evening in Johannesburg, the news spread like wildfire among sex workers: Within 24 hours, several nonprofit clinics providing free HIV services would be closing as President Donald Trump announced the United States was slashing foreign aid. Some South Africans living with, or at risk of, HIV secured supplies of life-saving drugs just in time. Others did not. Half a year later, the country with more people living with HIV than any other is struggling to treat its most vulnerable. Over 63,000 people were being treated in the 12 clinics across the nation that shut down. Up to 220,000 people have faced disruption to their daily HIV medication. South Africa's government has vowed it won't let the US withdrawal of about USD 427 million in support collapse its HIV program, the largest in the world. Sex workers, among the most vulnerable South Africans as their work is illegal, and transgender people spoke to The Associated Press on condition of anonymity for fear of retaliation

Pharmaceuticals & Biotech.

SECTOR | 21 Aug 2025

Why men are more likely to die from diabetes, hypertension and HIV

Business Standard

A global study in PLOS Medicine shows men have higher death rates from diabetes, hypertension and HIV/AIDS, largely due to risky lifestyles and lower healthcare use

Pharmaceuticals & Biotech.

SECTOR | 20 Aug 2025

Rains Making You Spend More? Breaking Down Seasonal Expenses From Transport To Medicines

NDTV Profit

Right from miscellaneous spends like umbrellas to season specific spends like medicines, planners warn that these monsoon can put one in a tight spot if not properly accounted for.